The overexpression of RARγ and its activation play roles in the abnormal behaviour of CSCs for a number of cancers that so far include some cases of AML, cholangiocarcinoma, colorectal, clear cell renal cell, hepatocellular, pancreatic ductal adenocarcinoma, prostate, and ovarian. The gene discussed is RARG; the disease is cholangiocarcinoma.